SARS-CoV-2 vaccine breakthrough infection in the older adults: a meta-analysis and systematic review

Xiaohui Jing, Menglin Han, Xiaoxuan Wang & Li Zhou BMC Infectious Diseases volume 23, Article number: 577 (2023) Cite this article Update published on 02 October 2023 Abstract Background Corona Virus Disease 2019 (COVID-19) mRNA vaccine effectiveness (VE) has recently…[...]

Read More

Incidence of New-Onset Hypertension Post–COVID-19: Comparison With Influenza

Vincent Zhang, Molly Fisher,Wei Hou,Lili Zhang and Tim Q. Duong    Aug 2023 https://doi.org/10.1161/HYPERTENSIONAHA.123.21174 Hypertension. 2023;0 Abstract BACKGROUND: SARS-CoV-2 may trigger new-onset persistent hypertension. This study investigated the incidence and risk factors associated…[...]

Read More

Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies

Melanie Dani,  Andreas Dirksen, Patricia Taraborrelli,  Miriam Torocastro, Dimitrios Panagopoulos, Richard Sutton, and Phang Boon Lim Clin Med (Lond). 2021 Jan; 21(1): e63–e67.  doi: 10.7861/clinmed.2020-0896 PMCID: PMC7850225 PMID: 33243837 ABSTRACT The SARS-CoV-2 (COVID-19) pandemic has caused unprecedented morbidity, mortality and global disruption.…[...]

Read More

Neurological manifestations of post-acute sequelae of COVID-19: which liquid biomarker should we use?

Dominique Comeau1† Mykella Martin2† Gilles A. Robichaud3,4,5 Ludivine Chamard-Witkowski2,6*1Dr. Georges-L. Long COVID syndrome, also known as post-acute sequelae of COVID-19 (PASC), is characterized by persistent symptoms lasting 3–12 weeks post SARS-CoV-2 infection. Patients suffering…[...]

Read More